A carregar...
Targeting epigenetics as atherosclerosis treatment: an updated view
This review discusses the current developments on epigenetic inhibition as treatment for atherosclerosis. RECENT FINDINGS: The first phase III clinical trial targeting epigenetics in cardiovascular disease (CVD), BETonMACE, using the bromodomain inhibitor apabetalone (RVX-208) showed no significant...
Na minha lista:
| Publicado no: | Curr Opin Lipidol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Lippincott Williams & Wilkins
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7752220/ https://ncbi.nlm.nih.gov/pubmed/33027226 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MOL.0000000000000711 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|